Impact of Hyperuricemia on Psoriatic Arthritis
Recruiting
- Conditions
- Psoriatic Arthritis
- Registration Number
- NCT06125444
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
Psoriatic arthritis and gout (linked to hyperuricemia) are two rheumatisms well known to rheumatologists. There are epidemiological and physiopathological arguments in favor of a non-fortuitous link between these two rheumatisms, which to date has not been established. There is currently no recommendation to treat hyperuricaemia without an episode of gout attack. We hypothesize that there is a link between hyperuricemia and severity of rheumatism. This would ultimately modify the therapeutic management of hyperuricemic patients followed for psoriatic arthritis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 242
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retrospectively determine the impact of hyperuricemia on the response to psoriatic arthritis treatments: inventory of the latest treatments in progress and the response to treatment according to the treating rheumatologist Files analysed retrospectively from January 01, 2009 to December 31, 2019 will be examined
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service de Rhumatologie - CHU de Strasbourg - France
🇫🇷Strasbourg, France